10-Q: DLH Holdings Reports Q1 Loss Amid Contract Shifts

DLH Holdings Corp. reported a net loss of $1.32 million for the quarter ended December 31, 2025, as revenue declined significantly due to contract conversions.

Summary

• Revenue for the three months ended December 31, 2025, decreased by $21.9 million to $68.9 million, down from $90.8 million in the prior year period.
• The company reported a net loss of $1.32 million, or $(0.09) per diluted share, compared to a net income of $1.12 million, or $0.08 per diluted share, in the same period last year.
• Income from operations fell sharply to $1.44 million from $5.64 million year-over-year.
• Non-GAAP Adjusted EBITDA decreased to $6.54 million from $9.94 million in the prior year quarter.
• The revenue decline was primarily attributed to the conversion of certain U.S. government contracts, particularly within the Department of Veterans Affairs (VA) CMOP program, to small business contractors.
• Backlog increased slightly to $517.4 million at December 31, 2025, from $514.3 million at September 30, 2025, with funded backlog rising to $124.0 million from $114.1 million.
• A goodwill impairment triggering event occurred due to a decrease in the company's share price, but a quantitative assessment concluded that goodwill was not impaired.
• Subsequent to the quarter, the company reduced general and administrative costs to align with expected revenue volume.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative report due to significant revenue decline, a swing to net loss, and reduced profitability metrics, primarily driven by contract losses to small businesses. While backlog increased and debt covenants are met, the underlying operational challenges are concerning.

Positives

• Backlog increased slightly to $517.4 million at December 31, 2025, from $514.3 million at September 30, 2025, indicating future potential revenue.
• Funded backlog increased to $124.0 million at December 31, 2025, from $114.1 million at September 30, 2025.
• The company remains in compliance with all loan covenants and restrictions as of December 31, 2025.
• Interest expense decreased by $0.7 million due to debt prepayment and a decrease in the floating interest rate.
• A new sole-source Indefinite Quantity/Indefinite Delivery (IDIQ) contract with a ceiling value of $90.0 million was awarded by the VA, effective October 28, 2025, with a maximum ordering period through October 2026.

Negatives

• Revenue decreased significantly by $21.9 million (24.1%) to $68.9 million for the quarter ended December 31, 2025, compared to $90.8 million in the prior year.
• The company reported a net loss of $1.32 million, a swing from a net income of $1.12 million in the prior year quarter.
• Basic and diluted earnings per share both turned negative to $(0.09) from $0.08.
• Income from operations decreased substantially by $4.2 million to $1.44 million.
• EBITDA decreased to $5.74 million from $9.94 million, and Adjusted EBITDA decreased to $6.54 million from $9.94 million.
• General and administrative costs increased as a percentage of revenue to 11.3% from 8.9% due to the decrease in revenue volume.
• The company's market capitalization declined below the recorded value of shareholder's equity, triggering a goodwill impairment assessment (though no impairment was recognized).

Risks

• Failure to achieve anticipated benefits from future acquisitions.
• Diversion of management's attention from daily operations and challenges of managing larger, widespread operations.
• Inability to retain employees and customers.
• Uncertainty in contract awards for re-competes and competition for new business.
• Challenges in managing debt obligations and complying with bank financial and other covenants.
• Changes in client budgetary priorities and government contract procurement risks (e.g., bid protests, small business set-asides, loss of work due to conflicts of interest, termination risks).
• Significant delays or reductions in appropriations for programs and broader changes in U.S. government funding and spending patterns.
• Legislation that amends or changes discretionary spending levels or budget priorities.
• Legal, regulatory, and political changes from the federal government that could result in economic uncertainty.
• Impact of inflation and higher interest rates.
• Non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on goodwill valuation in future periods.
• The effect of federal contractual set-aside laws and regulations, particularly the 'Rule of Two' for Service-Disabled Veteran Owned Small Businesses (SDVOSB), may limit the company's ability to compete for prime contractor positions, potentially relegating them to subcontractor roles.

Future Outlook

The company expects to continue aligning its capabilities with well-funded budget priorities and increasing organic growth within its addressable market, focusing on key national programs and mission-critical areas of health and national security. However, the U.S. budget and regulatory landscape remains uncertain, with potential impacts from changes in federal spending levels, small business set-asides, new administration priorities, and initiatives to reduce federal government spending. The company anticipates continuing to provide pharmacy and logistics services at remaining VA CMOP locations until procurement and transition processes are completed, and expects to perform a significant amount of business as a subcontractor should awards be offered to partners.

Management Comments

• "We believe we are advantageously positioned within our markets through a number of features including, but not limited to: highly credentialed workforce; predominantly performing as the prime contractor; strong past performance record across our government contracts; and strong bipartisan support for our key contracts."
• "We have invested in leading credentials and capabilities that we expect will deliver value to our customers."
• "We remain dependent upon the continuation of our relationships with our major customers as a significant portion of our revenue is concentrated in each of them."
• "Our results of operations, cash flows and financial condition would be materially adversely affected if we were unable to continue our relationship with any of these customers, if we were to lose any of our material current contracts, or if the amount of services we provide to them is materially reduced."
• "As this ongoing acquisition evaluation is occurring, DLH was awarded a new sole-source Indefinite Quantity/Indefinite Delivery ('IDIQ') contract effective October 28, 2025."
• "Until the VA has completed its procurement and transition processes, we expect to continue providing pharmacy and logistics services at these locations."
• "DLH intends to provide additional updates to the progression of these solicitations as a part of its regular quarterly and annual filings."
• "As we continue to align the Company's capabilities with well-funded budget priorities and the current budgetary environment, we believe we are well positioned to win new business in our large addressable market."
• "We are focused on increasing organic growth across our addressable market and delivering robust cash flow."
• "The Company does not expect this [partial government shutdown] to have a material impact on its operations and financial performance."
• "Should awards for the locations for which we have submitted a proposal be offered to a partner of DLH, we expect to continue to perform a significant amount of those contracts' volume of business as a subcontractor."
• "Subsequent to the end of the quarter, we reduced general and administrative costs to align more closely with our expected revenue volume."
• "We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements."

Industry Context

StockSavvy.ai notes that the U.S. government contracting sector, particularly in health and defense, is subject to significant budgetary and regulatory shifts. The emphasis on small business set-asides, such as the VA's 'Rule of Two' for SDVOSBs, presents both challenges and opportunities for larger prime contractors like DLH. While DLH is adapting by pursuing subcontractor roles, this trend can compress margins and reduce direct revenue control. The broader industry also faces ongoing uncertainty from federal budget processes and evolving administration priorities, requiring contractors to maintain agile cost structures and align capabilities with shifting government needs.

Comparison to Industry Standards

• The significant revenue decline of 24.1% and the swing to a net loss are considerably worse than typical industry growth expectations for established government contractors, which often aim for stable, albeit modest, growth.
• The decrease in Adjusted EBITDA from $9.94 million to $6.54 million reflects a substantial erosion of operational profitability, contrasting with peers who might be experiencing more stable or growing EBITDA margins in a generally robust government spending environment.
• While the increase in backlog is a positive, the underlying reason for revenue decline (contract conversions to small businesses) indicates a structural challenge that may not be fully offset by new prime contract wins or subcontractor roles, unlike companies that maintain prime status on key programs.
• The triggering of a goodwill impairment assessment, even without actual impairment, suggests a market valuation concern that is more pronounced than for many stable government services firms, whose market capitalizations typically remain well above book value.

Corporate Governance

Legal Proceedings

• The company is subject to various claims and legal actions in the ordinary course of business, including professional liability, employment-relations issues, workers compensation, tax, payroll, and other commercial disputes.
• Management is not aware of any pending or threatened litigation that is reasonably likely to have a material adverse effect on its results of operations, financial position, or cash flows.

Related Party Transactions

• No significant related party transactions occurred for the three months ended December 31, 2025 and 2024, requiring disclosure.

Stakeholder Impact

• Shareholders: Experienced a net loss and negative EPS, indicating reduced profitability and potential impact on shareholder value.
• Employees: General and administrative costs were reduced subsequent to the quarter end to align with expected revenue volume, potentially impacting employee headcount or compensation.
• Customers (VA): The transition of CMOP contracts to SDVOSB prime contractors means DLH will continue to serve some locations as prime until transition, and potentially as a subcontractor thereafter, maintaining service continuity.
• Creditors: The company remains in compliance with all loan covenants, indicating sound management of debt obligations despite operational challenges.

Next Steps

• Continue providing pharmacy and logistics services at remaining VA CMOP locations until the VA completes its procurement and transition processes.
• Provide additional updates on the progression of VA CMOP solicitations in regular quarterly and annual filings.
• Align company capabilities with well-funded budget priorities and maintain a competitive cost structure.
• Focus on increasing organic growth across the addressable market and delivering robust cash flow.
• Adopt ASU 2023-09 (Income Tax Disclosures) in the Annual Report on Form 10-K for the fiscal year ending September 30, 2026.
• Evaluate impacts of SEC's final rule on climate-related disclosures, effective for annual reports for the year ending December 31, 2027, for smaller reporting companies.
• Evaluate impacts of ASU 2024-03 (Expense Disaggregation Disclosures), effective for annual reporting periods beginning after December 15, 2026.

Key Dates

Recommendation

The significant decline in revenue, coupled with a swing to a net loss and reduced EBITDA, indicates a deteriorating financial performance. While backlog shows a slight increase and debt covenants are met, the underlying cause of revenue loss (contract conversions to small businesses) represents a structural challenge in its core government contracting market. The need for post-quarter G&A cost reductions further signals operational stress. Given the negative financial trends and ongoing market uncertainties, a seasoned investor would likely recommend selling to mitigate further downside risk.

Keywords

Government contracting, Federal services, Health IT, Cybersecurity, Veterans Affairs, Department of Defense, HHS, 10-Q, Financial results, Revenue decline, Net loss, Backlog, Goodwill impairment, Debt covenants, SDVOSB, Contract conversion